Vitamin D supplementation in pregnancy, prenatal 25(OH)D levels, race, and subsequent asthma or recurrent wheeze in offspring: Secondary analyses from the Vitamin D Antenatal Asthma Reduction Trial Helene M. Wolsk, MD, Benjamin J. Harshfield, BA, Nancy Laranjo, BA, Vincent J. Carey, PhD, George O'Connor, MD, Megan Sandel, MD, Robert C. Strunk, MD, Leonard B. Bacharier, MD, Robert S. Zeiger, MD, Michael Schatz, MD, Bruce W. Hollis, PhD, Scott T. Weiss, MD, Augusto A. Litonjua, MD, MPH Journal of Allergy and Clinical Immunology Volume 140, Issue 5, Pages 1423-1429.e5 (November 2017) DOI: 10.1016/j.jaci.2017.01.013 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Journal of Allergy and Clinical Immunology 2017 140, 1423-1429 Journal of Allergy and Clinical Immunology 2017 140, 1423-1429.e5DOI: (10.1016/j.jaci.2017.01.013) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 CONSORT 2010 flow diagram. Journal of Allergy and Clinical Immunology 2017 140, 1423-1429.e5DOI: (10.1016/j.jaci.2017.01.013) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 2 Plot of 25(OH)D levels at entry into the trial divided by race and treatment group. Other refers to Asian, Native Hawaiian or other Pacific Islander, American Indian/Alaskan Native, or others. Journal of Allergy and Clinical Immunology 2017 140, 1423-1429.e5DOI: (10.1016/j.jaci.2017.01.013) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions